论文部分内容阅读
Objectives Spironolactone,an aldosterone receptor blocker,has been shown to be beneficial in patients with chronic severe heart failure.We tested whether low dose spironolactone is safe and effective in patients with chronic heart failure and mild symptom over a five years period.